Sign in
4

Changes in Ownership

Oruka Therapeutics, Inc. Filed Acc 0000907654-26-000032

Senior Vice President, Finance sold 395 shares at $41.30 ($16,314)

From the SEC's structured data for this filing

Trades in this filing

Agarwal Arjun · Senior Vice President, Finance

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2026-03-16 Sale : show line 1 in the form −395 $41.30 $16,314 18,863 D
Open-market sales · 395 sh · avg $41.30 · $16,314
Loading xslF345X05/form4.xml…